Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z

Media Relations
Media Home Page | Contact Us
US Department of Health and Human Services logo and link

Media Relations Links
• About Us
• Media Contact
• Frequently Asked Questions
• Media Site Map

CDC News
• Press Release Library
• Transcripts
• MMWR Summaries
• B-Roll Footage
• Upcoming Events

Related Links
• Centers at CDC
• Data and Statistics
• Health Topics A-Z
• Image Library
• Publications, Software and Other Products
• Global Health Odyssey
Find your state or local health department
HHS News
National Health Observances
Visit the FirstGov Web Site
Div. of Media Relations
1600 Clifton Road
MS D-14
Atlanta, GA 30333
(404) 639-3286
Fax (404) 639-7394

 


CDC Telebriefing Transcript
Drs. Feldman and Hayes Discuss Tularemia

March 7, 2002

CDC MODERATOR: Good morning. Well, I guess good afternoon, everyone. Thank you for joining us on today's MMWR telebriefing. Today, we're going to be focusing on the article, "Tularemia, United States, 1990 through 2000," and we have joining us Drs. Katherine Feldman and Dr. Ned Hayes, both who are CDC's zoonotic disease experts.

I'd just like to take a moment to point out the other two articles that are featured in this week's MMWR. They are the "Point of Purchase, Tobacco Environment and Variation by Store Type, United States, 1999," and "Variation in Homicide Risk During Infancy,, United States, 1989 to 1998." If you have any questions on either of those two articles, you can call the CDC press line at [404] 639-3286.

And now I'm going to turn it over to Dr. Feldman who's going to give a couple brief remarks and then we will open it up to questions and answers of which Dr. Feldman and Dr. Hayes will both be available.

Dr. Feldman.

DR. FELDMAN: Okay. Good morning.

Tularemia, often known as rabbit fever or deer fly fever, is a bacterial zoonosis caused by Francisella tularensis. Following a dramatic decline in the second half of the 20th Century, the incidence of Tularemia in the United States remains low, with an average of 124 cases reported annually during the period 1990 to 2000.

This indicates a low level of natural transmission, most often via tick bites that occurred throughout the United States. Tularemia can be prevented by using personal protective measures against tick bites by avoiding dead or sick animals, and by wearing gloves when handling or dressing wild rabbits.

Understanding the epidemiology of tularemia enables clinicians and public health practitioners to recognize unusual patterns of disease occurrence that might signal an outbreak or a bioterrorism event. That's it.

CDC MODERATOR: We'll open it up for questions and answers now.

AT&T MODERATOR: Thank you, and, once again, ladies and gentlemen, if you do have a question, please press the one at this time.

We do have a question from the line of Emma Hitz [ph] with Reuters Health. Please go ahead.

MS. HITZ: Yes. Hi. I have two questions. Could you tell me what makes Tularemia a suitable biological warfare agent, and also can you address why you think Arkansas and Missouri contribute such a high number of cases to this disease.

DR. FELDMAN: Okay; sure. I'll address the first question first. Francisella tularensis is a category A agent and the reason for this is probably because it's highly infectious. As few as 10 to 50 organisms, either inhaled, or injected, can reliably cause disease. The disease that results can be a severe disease and, in addition, it can be transmitted in various ways, including through an aerosol exposure or through contamination of food and water. Natural transmission also occurs via arthropod bites and direct contact with infected animal tissues.

In a bioterrorism event, an aerosol release would probably have the greatest adverse medical and public health consequences.

In response to your second question, why Arkansas and Missouri probably have such a high number of cases, there's a lot that's still unknown about the natural transmission of Tularemia, and we do know that the organism can infect a vast array of mammals, birds, and ticks, and that most transmission in the U.S., natural transmission, is through tick bites.

Both Arkansas and Missouri have prime habitat and conditions to favor tick populations, including moist areas with thick underbrush.

In addition, in that area, there are at least two tick species that can transmit the disease to humans, and once the disease is in ticks, it can become endemic in the animal population.

MS. HITZ: Great; thanks a lot.

DR. FELDMAN: Sure thing.

AT&T MODERATOR: And we have a question from the line of Kim Dixon with Bloomberg News. Please go ahead.

MS. DIXON: Hi; thanks. Two questions. The first is, Can you break it down in the last decade. You said it's an average of 124 reported cases a year. Is there a trend in one direction or the other, or is it more or less the same? And, also, what's the fatality rate?

DR. FELDMAN: There was not a significant trend noted. In the text of the article, you'll note that the disease is nationally notifiable. However, there was a period in the middle of the decade from mid '91 until 1999, where the disease was not nationally notifiable.

So there wasn't a noticeable trend throughout the decade and that can be attributed to both the lapse in notifiable status and just also random variation in natural transmission of Tularemia.

MS. DIXON: And the fatality rate? What percentage of people who get it--

DR. FELDMAN: Oh, right; right. Okay. So prior to the antibiotic era, the untreated cases had an overall mortality rate of 5 to 15 percent, and that is overall. Tularemia is an interesting disease in that it can result in various clinical presentations, ranging from the most common form which is the ulcer or glandular form, which is manifested by an ulcer and enlarged lymph node, to the pneumonic form which is the most severe form.

So, again, overall, the case fatality rate in untreated patients is 5 to 15 percent. It can be as high as 60 percent in untreated patients with the pneumonic form of the disease.

MS. DIXON: Is it similar to anthrax in that by the time the symptoms happen, it's too late to treat? Or is it different in that way?

DR. FELDMAN: Absolutely not, and that's the next point I wanted to mention. It is a treatable disease, it's a bacterial disease, it has a slower progression than some of the other agents used in biological warfare such as anthrax and plague. It has a slower progression, and this can lend itself to maybe being more amenable to treatment early on, and once treated, survival is quite high if it's treated promptly. Mortality is less than one percent.

MS. DIXON: Once treated; okay.

DR. FELDMAN: Once treated.

MS. DIXON: Thanks.

AT&T MODERATOR: And, again, ladies and gentlemen, if you do have a question, please press the one at this time. And to the presenters on the call, no further questions in queue.

CDC MODERATOR: Dr. Feldman, are there any points in your article that you think are important for people to understand, or some things that you want to highlight in this opportunity?

DR. FELDMAN: Well, I do just want to reinforce prevention measures against Tularemia in natural occurrence, and that would be primarily because it's most commonly transmitted through tick bites, by the use of personal protective measures against tick bites. This would include avoiding tick-infested habitats on the use of repellent, and frequent tick checks, and wearing protective clothing against tick bites.

In addition, avoiding dead or sick animals, and wearing gloves when handling or dressing wild rabbits can help prevent Tularemia.

CDC MODERATOR: Okay. Dr. Hayes, is there anything that you wanted to add?

DR. HAYES: I think Dr. Feldman's covered it very nicely. Thank you all very much for your interest.

CDC MODERATOR: Okay. Thank you very much.

AT&T MODERATOR: And ladies and gentlemen, that does conclude your conference for today. Thank you for your participation. You may now disconnect.

[END OF TAPE RECORDING.]

Listen to the telebriefing


Media Home Page | Accessibility | Privacy Policy | Contact Us

CDC Home | Search | Health Topics A-Z

This page last updated March 7, 2002
URL:

United States Department of Health and Human Services
Centers for Disease Control and Prevention
Office of Communication
Division of Media Relations